Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Neurofibromatosis type 2 (NF2): diagnosis and management.

Lloyd SK, Evans DG.

Handb Clin Neurol. 2013;115:957-67. doi: 10.1016/B978-0-444-52902-2.00054-0. Review.

PMID:
23931824
2.

Neurofibromatosis type 2.

Evans GR, Lloyd SK, Ramsden RT.

Adv Otorhinolaryngol. 2011;70:91-8. doi: 10.1159/000322482. Epub 2011 Feb 24. Review.

PMID:
21358190
3.

Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].

Evans DG.

Genet Med. 2009 Sep;11(9):599-610. doi: 10.1097/GIM.0b013e3181ac9a27. Review.

PMID:
19652604
4.

Neurofibromatosis type 2 (NF2): a clinical and molecular review.

Evans DG.

Orphanet J Rare Dis. 2009 Jun 19;4:16. doi: 10.1186/1750-1172-4-16. Review.

5.

Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.

Ruggieri M, Praticò AD, Evans DG.

Semin Pediatr Neurol. 2015 Dec;22(4):240-58. doi: 10.1016/j.spen.2015.10.008. Epub 2015 Oct 28. Review.

PMID:
26706012
6.

Neurofibromatosis type 2.

Evans DG.

Handb Clin Neurol. 2015;132:87-96. doi: 10.1016/B978-0-444-62702-5.00005-6. Review.

PMID:
26564072
8.

A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.

Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X, Yuan J, Territo P, Hutchins G, Nalepa G, Yang FC, Conway SJ, Heinz MG, Stemmer-Rachamimov A, Yates CW, Wade Clapp D.

Hum Mol Genet. 2015 Jan 1;24(1):1-8. doi: 10.1093/hmg/ddu414. Epub 2014 Aug 11.

9.

[Neurofibromatosis type 2].

Pérez-Grau M, Miró N, Prades J, Vergés J, Lareo S, Roca-Ribas F.

Acta Otorrinolaringol Esp. 2010 Jul-Aug;61(4):306-11. doi: 10.1016/j.otorri.2009.12.005. Epub 2010 Feb 6. Review. Spanish.

10.

Further genotype--phenotype correlations in neurofibromatosis 2.

Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG.

Clin Genet. 2010 Feb;77(2):163-70. doi: 10.1111/j.1399-0004.2009.01315.x. Epub 2009 Nov 23.

PMID:
19968670
11.

[Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].

Drouet A, Le Moigne F, Salamé D, Quesnel L, Motolese C, des Portes V, Guilloton L, Pinson S.

Arch Pediatr. 2014 Nov;21(11):1233-40. doi: 10.1016/j.arcped.2014.08.031. Epub 2014 Oct 22. French.

PMID:
25439059
12.

Neurofibromatosis type 2.

Evans DG, Sainio M, Baser ME.

J Med Genet. 2000 Dec;37(12):897-904. Review. Erratum in: J Med Genet 2001 Oct;38(10):727a.

13.

[Phenotype-genotype study in 154 French NF2 mutation carriers].

Demange L, De Moncuit C, Thomas G, Olschwang S.

Rev Neurol (Paris). 2007 Nov;163(11):1031-8. French.

PMID:
18033041
14.

Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.

Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF.

Neurogenetics. 1999 Apr;2(2):101-8.

PMID:
10369886
15.

Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.

Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN.

J Neuropathol Exp Neurol. 1998 Dec;57(12):1164-7.

PMID:
9862639
16.

Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.

Ferrer M, Schulze A, Gonzalez S, Ferreiro V, Ciavarelli P, Otero J, Giliberto F, Basso A, Szijan I.

Neurosci Lett. 2010 Aug 9;480(1):49-54. doi: 10.1016/j.neulet.2010.05.094. Epub 2010 Jun 8.

PMID:
20553997
17.

The neurofibromatosis type 2 gene is inactivated in schwannomas.

Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA.

Hum Mol Genet. 1994 Jan;3(1):147-51.

PMID:
8162016
18.

Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L.

Neuropediatrics. 2005 Feb;36(1):21-34.

PMID:
15776319
19.

Neurofibromatosis 2.

Evans DG.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
1998 Oct 14 [updated 2011 Aug 18].

20.

[Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].

Sabol Z, Kipke-Sabol L, Miklić P, Hajnsek-Propadalo S, Sabol F.

Lijec Vjesn. 2006 Sep-Oct;128(9-10):309-16. Review. Croatian.

PMID:
17128670

Supplemental Content

Support Center